Application no. and date | 09835796.5 (espacenet) (Federated) (European Patent Register), 20091222 | Patent/reg. no. and date | DK/EP 2376075, 20150408 | Publication date | 20111019 | Priority no. and date | US 140034 P, 20081222 | EP pub. no. and date |
EP 2376075 20111019 | Effective date | | Applicant/owner | Evoke Pharma, Inc., 505 Lomas Santa Fe Drive, Suite 270
Solana Beach, CA 92075, US | Applicant ref. no. | P55947DK01 | Inventor | D'ONOFRIO, Matthew, J., 4275 Calle Mar de Ballenas
San Diego California 92130, US, GONYER, David, A., 1715 Haydn Drive
Cardiff California 92007, US, SHAH, Shirish, A., 2814 W Wildwood Drive
Phoenix Arizona 85045, US, MADDEN, Stuart, J., 4608 Autumn Woods Way
Ellicott City Maryland 21043, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/14 (2006.01) , A61K 31/166 (2006.01) , A61K 47/12 (2006.01) , A61K 9/00 (2006.01) , A61K 9/08 (2006.01) , A61P 1/08 (2006.01) | Title | NASALE FORMULERINGER AF METOCLOPRAMID | Int. application no. | US2009069298 | Int. publication no. | WO2010075444 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|